| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024368 |
| Receipt No. | R000028049 |
| Official scientific title of the study | Concurrent, daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer, Exploratory Trial |
| Date of disclosure of the study information | 2016/10/12 |
| Last modified on | 2016/10/11 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Concurrent, daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer, Exploratory Trial
|
|
| Title of the study (Brief title) | Concurrent, daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer, Exploratory Trial
|
|
| Region |
|
|
| Condition | ||
| Condition | cervical cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy of concurrent daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | Overall survival by histology
Overall survival by age Adverse effects |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | A total dose of 50 Gy was delivered in 25 daily fractions of2.0 Gy, administered on 5 days a week
CDDP: 8 mg/m2/day weekday x 25 |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Patients with stage IIA to IIIB cervical cancer
according to the International Federation of Gynecologyand Obstetrics, 2) Cervical carcinoma of the non- small cell type (squamous, adenosquamous, and adenocarcinoma), were selected. 3) no previous chemotherapy or radiotherapy 4) ECOG performance status 0-2 5) Leukocyte count of 3,000/mm3 or higher, neutrophil count of 2,000/mm3 or higher, platelet count of 100,000/mm3 or higher, serum creatinine 1.5 mg/dl or less 6)) normal chest radiograph and electrocardiogram. |
|||
| Key exclusion criteria | 1) positive para aortic lymph node swelling
2) severe systemic or uncontrolled disease (uncontrolled diabetes mellitus or hypertension) 3) severe infection that precluded the use of chemotherapy 4) preexisting neuropathy from any cause, pregnancy or lactation 5) mental illness 6) previous or concomitant malignancies |
|||
| Target sample size | 65 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Mitsuhashi |
| Organization | Graduate School of Medicine, Chiba University |
| Division name | Reproductive Medicine |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan |
| TEL | 043-222-7171 |
| antira@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | AKIra Mitsuhashi |
| Organization | Graduate School of Medicine, Chiba University |
| Division name | Reproductive Medicine |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan |
| TEL | 043-222-7171 |
| Homepage URL | |
| antira@faculty.chbia-u.jp | |
| Sponsor | |
| Institute | Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028049 |